Similarly to that observed in preclinical experiments, Lutz et al.[200] reported that 33 out of 39 resected tumor tissues of GVAX-vaccinated patients were characterized by the presence of intratumoral tertiary lymphoid aggregates, together with an upregulation of the PD-1/PD-L1 pathway. This evidence concerns the gene PDCD1 and neoplasm.